Given that PP has been shown to inhibit glucagon secretion through the PPYR-1 receptors in α cells (122), an increase in islet PP could be another means by which glucagon (and thereby insulin) release could be impaired in CF. This evidence concerns the gene INS and cystic fibrosis.